We are live on !
Find out more
GW & Wade Portfolio holdings
AUM
$3.08B
Turnover
13.09%
1-Year Est. Return
18.99%
This Fund
S&P 500
This Quarter Est. Return
+10.54%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$3.08B
AUM Growth
+$391M
(+15%)
Cap. Flow
+$120M
Cap. Flow % of AUM
Cap. Flow %
3.91%
Top 10 Holdings %
Top 10 Hldgs %
31.13%
Holding
443
New
32
Increased
183
Reduced
144
Closed
26
Avg Time Held
4.3
years
Top 10 Avg Time Held
4.5
years
Top 20 Avg Time Held
5.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$38.7M |
| 2 |
Pacer US Cash Cows 100 ETF
COWZ
|
+$13M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$12.8M |
| 4 |
Broadcom
AVGO
|
+$8.98M |
| 5 |
iShares Russell 1000 ETF
IWB
|
+$8.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$12.5M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$7.84M |
| 3 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
+$7.04M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$5.04M |
| 5 |
iShares Select Dividend ETF
DVY
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.06% |
| 2 | Technology | 13.97% |
| 3 | Financials | 6.24% |
| 4 | Healthcare | 6.05% |
| 5 | Consumer Staples | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Vodafone
VOD
$35.9B
| $111K | ﹤0.01% |
12,752
-1,002
| -7% | -$9.15K |
2017 Q1
27 quarters
|
|
402
Eaton Vance Limited Duration Income Fund
EVV
$1B
| $97K | ﹤0.01% |
+10,079
| New | +$91.8K |
2023 Q4
0 quarters
|
|
403
SiriusXM
SIRI
$10.8B
| $91K | ﹤0.01% |
1,655
| – | – |
2015 Q1
35 quarters
|
|
404
Research Frontiers
REFR
$12.9M
| $73K | ﹤0.01% |
+72,615
| New | +$75.4K |
2023 Q4
0 quarters
|
|
405
Karyopharm Therapeutics
KPTI
$395K
| $39K | ﹤0.01% |
3,009
| – | – |
2023 Q3
1 quarter
|
|
406
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $30K | ﹤0.01% |
10,000
| – | – |
2022 Q2
6 quarters
|
|
407
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $13K | ﹤0.01% |
545
| – | – |
2023 Q1
3 quarters
|
|
408
Baidu
BIDU
$27.1B
| – | – |
-1,940
| Closed | -$261K | – |
|
409
Scotiabank
BNS
$113B
| – | – |
-4,925
| Closed | -$225K | – |
|
410
Clorox
CLX
$12.9B
| – | – |
-1,581
| Closed | -$207K | – |
|
411
Canadian National Railway
CNI
$76B
| – | – |
-3,057
| Closed | -$331K | – |
|
412
Corteva
CTVA
$8.12B
| – | – |
-4,112
| Closed | -$210K | – |
|
413
Diageo
DEO
$56.6B
| – | – |
-1,444
| Closed | -$215K | – |
|
414
WisdomTree US SmallCap Dividend Fund
DES
$2.12B
| – | – |
-7,331
| Closed | -$207K | – |
|
415
Precision BioSciences
DTIL
$265M
| – | – |
-470
| Closed | -$5K | – |
|
416
eBay
EBAY
$54.2B
| – | – |
-6,048
| Closed | -$267K | – |
|
417
Enbridge
ENB
$106B
| – | – |
-7,242
| Closed | -$240K | – |
|
418
Foghorn Therapeutics
FHTX
$114M
| – | – |
-107,770
| Closed | -$539K | – |
|
419
Halliburton
HAL
$26.4B
| – | – |
-5,913
| Closed | -$239K | – |
|
420
iShares Self-Driving EV and Tech ETF
IDRV
$121M
| – | – |
-7,039
| Closed | -$262K | – |
|
421
International Flavors & Fragrances
IFF
$20.8B
| – | – |
-3,939
| Closed | -$268K | – |
|
422
iShares Core MSCI Total International Stock ETF
IXUS
$57.7B
| – | – |
-5,725
| Closed | -$343K | – |
|
423
iShares US Healthcare ETF
IYH
$4.82B
| – | – |
-4,705
| Closed | -$254K | – |
|
424
NET Power
NPWR
$73.9M
| – | – |
-10,000
| Closed | -$151K | – |
|
425
Invesco WilderHill Clean Energy ETF
PBW
$297M
| – | – |
-100,432
| Closed | -$3.16M | – |
|
Similar funds
GW & Wade's Q4 2023 Portfolio in Review
As of Q4 2023, GW & Wade held 443 positions worth $3.08B, up 15% from $2.69B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
GW & Wade deployed $120M of net new capital in Q4 2023, opening 32 new positions and adding to 183 existing holdings. Its largest new stake was Fidelity Total Bond ETF: 290,986 shares worth $13.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $12.5M trimmed.
- GW & Wade's largest Q4 2023 buy was Fidelity Total Bond ETF: 290,986 shares worth $13.4M.
- GW & Wade added most to iShares 7-10 Year Treasury Bond ETF in Q4 2023, an estimated $38.7M increase.
- GW & Wade's biggest Q4 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $12.5M.
- GW & Wade fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $7.04M.
- GW & Wade's ten largest holdings make up 31% of its $3.08B portfolio in Q4 2023.
- GW & Wade opened 32 new positions and closed 26 in Q4 2023.
- GW & Wade's portfolio value rose 15% quarter-over-quarter to $3.08B.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.